Market closedNon-fractional
Regencell Bioscience/RGC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Regencell Bioscience
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Ticker
RGC
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Causeway Bay, Hong Kong
Employees
12
Website
www.regencellbioscience.com
RGC Metrics
BasicAdvanced
$119M
Market cap
-
P/E ratio
-$0.36
EPS
-0.47
Beta
-
Dividend rate
Price and volume
Market cap
$119M
Beta
-0.47
Financial strength
Management effectiveness
Return on assets (TTM)
-24.77%
Return on equity (TTM)
-39.72%
Valuation
Price to book
11.68
Price to tangible book (TTM)
11.68
Growth
Earnings per share change (TTM)
-33.46%
3-year earnings per share growth (CAGR)
62.20%
RGC Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 22
QoQ growth
Revenue
$0
NaN%
Net income
-$3.8M
8.57%
Profit margin
0.00%
NaN%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Regencell Bioscience stock?
Regencell Bioscience (RGC) has a market cap of $119M as of July 27, 2024.
What is the P/E ratio for Regencell Bioscience stock?
The price to earnings (P/E) ratio for Regencell Bioscience (RGC) stock is 0 as of July 27, 2024.
Does Regencell Bioscience stock pay dividends?
No, Regencell Bioscience (RGC) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Regencell Bioscience dividend payment date?
Regencell Bioscience (RGC) stock does not pay dividends to its shareholders.
What is the beta indicator for Regencell Bioscience?
Regencell Bioscience (RGC) has a beta rating of -0.47. This means that it has an inverse relation to market volatility.
Buy or sell Regencell Bioscience stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.